Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Post by SouthernTierTomon Dec 07, 2021 12:43pm
157 Views
Post# 34206798

Does anyone know who was "in charge of the phase 3 data"?

Does anyone know who was "in charge of the phase 3 data"?

WOW - that 42.5 cent US financing is looking "like a fare deal" now

WINK - WINK - nudge nudge ; - )

Well Canada...."WHAD UP"? seriously though....

Euphrates finished at 88 PMX and 106 "SHAM" in the 194 group

If we removed the 16 patients from Canada, how did the totals grow to 90 PMX and 89 "SHAM", as per the offered numbers in the reveal of 26 pateints or 1 more than previous report?

Has CANADA ever had a patient actually treated with PMX? how many and where?

This little 15 cent game in tax loss season is DISGUSTING!

As are the little "Spectral bullboard elves" liking the posts that "discredit" the truth faster than the stock can be SHORTED on the US OTC dirt level and be played with like a "bag o toys"

I have a much deeper understanding of MODs vs, SOFA than most of you, I see it too as another interesting puzzle piece.

The phase 2 trial process is supposed to be the "potluck" offering and the phase 3 the "refinement" and deeeep focus on where it works and how it can get to market.  Somehow, we've managed to flip the phase 2 and phase 3 process and allow for the "Johnny come latelys" to cash in our long and patient support of these dudes and their 20+ year compensation plan.  If I was Canadien I would be furious at the "current claims" of wonderful efficacy and the fact Canada has had FULL approval on this EAA / PMX theranostic for nearly 20 years!  We can amp up the language and confuse the naive, but the translocation of endotoxin has been going on since 1994 when the Japanese fully approved PMX and applied it's use primarily to abdominal sepsis.  The fact "HE" blames the current share price on their inability to trade on a real exchange in the US in short order is $ICK!  The DELIST here in the US 5 years ago and the daily SHORTing on the US OTC dirt level is enough to make any loyal shareholder vomit.  More everything for those closest to this play.  Suddenly one former supporter of ALL those companies now apparently with "NOTHING" ( from a sepsis standpoint ) will decide whether we focus on the pandemic?  REALLY??..I've noticed the former CEO's name is NOT even mentioned anymore...NOTHING of signifigance has really changed since the Euphas phase 2 produced 21% over 12 years ago.  The ONLY reason, in my humble opinion, something takes this long, given it's safety profile, 300K known applications and it's potential service to a massive unmet need is the fact that too many important people want a discounted ticket for the "train ride" IMHO

GROSS .... and I'm the wrong cat to challenge... I own too much and know waaay too much about this entire $aga.

That said...I welcome the challenge...you think you know where to find me Don.

They've ( the bullboard elves )have been asked / told to advertise a rev split/ ROLLBACK / disgusting escortation of share price suppression

I'm more curious about the 4,000 Baxter Prismax units installed all across America. The PMX filter works quite nicely inside them and critically ill covid19 patients are loaded with endotoxin, let's take it out and see what happens ( to quote Dr. Phil )
 

Most of the call Thursday sounded like an apology and explanation for dragging this out. I noticed OMICRON in big bold letters and moreso the comment about deviating to focus on cv19 and a comparison to the "next thing to come along" The CV19 pandemic has been turned into a one-way street of doom and 15 cent gloom for EDT shareholders.  Confusing, when our former CEO and true pioneer of our current siuation claimed, he was "proud" to see ALL our products activated to assist in the pandemic.  WHAT happened, the pandemic is NOT Norwalk or a bad flu season, it is a once in a century event that appears to be leveraged as a furhter opportunity to lengthen the glorious train ride.

Is a once a century pandemic in the category of the "next thing to come along"?

The polar "bear" express is claiming as close to 100% as possible in regards to reaching it's destination but wants to make ALL the $top$ .. that is no "BULL"

CMO's words very, very strong and the multi-year dodging of a  US listing means they aren't interested in coughing up their paper at these levels OR increasing the ACB for future "benefits"...imho, they have FULL control, a US listing would create a share management issue at this level.

Hey Canada..it's NOT really your fault, the FDA is a mighty organization and your country a rather weak 37 MILLION or so with little say or do with global say in the world of theranostics and such - IMHO

Do your own DD ( due diligence ) and NEVER , EVER take ANY advice from the intra-net, seek professional help always on matters of $100 or more.

 

Long EDT!!!

<< Previous
Bullboard Posts
Next >>